|
|
||||||||
1 Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York 14214-3005; and 2 Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China 430060
| |
ABSTRACT |
|---|
|
|
|---|
Kv1.4 encodes a slowly
recovering transient outward current (Ito),
which inactivates by a fast N-type (intracellular ball and chain)
mechanism but has slow recovery due to C-type inactivation. C-type
inactivation of the NH2-terminal deletion mutant
(fKv1.4
N) was inhibited by 98 mM extracellular K+
concentration ([K+]o), whereas N-type
was unaffected. In 98 mM [K+]o, removal of
intracellular K+ concentration
([K+]i) speeded C-type inactivation but had
no effect on N-type inactivation, suggesting that C-type inactivation
is sensitive to K+ binding to intracellular sites. C-type
inactivation is thought to involve closure of the extracellular pore
mouth. However, a valine to alanine mutation on the intracellular side
of S6 (V561A) of fKv1.4
N alters recovery and results in anomalous
speeding of C-type inactivation with increasing
[K+]o. Extracellular pH (pHo)
modulated both N- and C-type inactivation through an S5-H5 linker
histidine (H508) with acidosis speeding both N- and C-type
inactivation. Mutation of an extracellular lysine to a tyrosine (K532Y)
slowed C-type inactivation and inhibited the pH dependence of both N-
and C-type inactivation. These results suggest that mutations,
[K+], and pH modulate inactivation through
membrane-spanning mechanisms involving S6.
voltage-gated channel; ion; Kv1.1; ataxia
| |
INTRODUCTION |
|---|
|
|
|---|
A RAPIDLY INACTIVATING K+ channel is Kv1.4, which is thought to form the molecular basis for a rapidly inactivating, slowly recovering, transient outward current in the endocardium of several mammalian species, including humans (3). Its expression is upregulated in the mammalian endocardium during hypertrophy and heart failure (15, 26, 27, 34). Understanding the inactivation and recovery mechanisms of this channel is critical to understanding the ionic dependence, response to acidosis and alkalosis, drug affinity, and use-dependent drug-binding properties (38, 44). Kv1.4 inactivates by two well-established processes: N- and C-type inactivation. N-type inactivation is fairly well characterized and results from the occlusion of the intracellular side of the pore by a "ball and chain" mechanism formed by the NH2 terminus of the channel molecule (20, 21, 24, 25, 32, 49). C-type inactivation is not so well understood but appears to involve conformational changes on the extracellular side of the pore (29) because it is sensitive to extracellular permeant ions (22, 31, 38), extracellular tetraethylammonium (2, 7, 22, 28), and mutations near the extracellular mouth of the channel (6, 14, 40). C-type inactivation is thought to be closely related to the "slow" inactivation mechanisms observed in calcium and sodium channels. Despite their different molecular bases, these mechanisms are coupled (21): C-type inactivation is more rapid in the presence of N-type inactivation (4). Recovery from inactivation is controlled by the slower C-type mechanism (37), making it physiologically important.
Two nonmutually exclusive mechanisms have been proposed to explain the coupling between N-type inactivation, an intracellular event (20, 21, 25, 32, 49), and C-type inactivation (29, 31, 36), an extracellular event. The Permeation Hypothesis is based on the fact that movement of K+ through the pore can result in a localized extracellular K+ concentration ([K+]o) accumulation (4). These ions can bind to an extracellular site and thus slow C-type inactivation. Coupling occurs when the NH2 terminus of the channel blocks the flow of K+, dissipating the [K+]o accumulation and increasing C-type inactivation (4). An alternative proposal for N- and C-type inactivation coupling is the Allosteric Hypothesis, in which the NH2-terminal binding during N-type inactivation stabilizes the transmembrane segments of the channel into a conformation that promotes the development of C-type inactivation (37, 38). The Allosteric Hypothesis still allows for modulation of inactivation by [K+]o via an extracellular binding site, but this is not the way in which the two inactivation processes are linked.
In this study, we demonstrate that even though N- and C-type inactivation is associated with intracellular and extracellular events, respectively, they are both strongly influenced by events occurring at pore sites physically distant from their major site of action. These global conformational changes are responsible for the pH and [K+]o dependency of N- and C-type inactivation. They suggest an important physiological role for allosteric coupling between the intracellular and extracellular domains of the Kv1.4 channel.
| |
METHODS |
|---|
|
|
|---|
Mature female Xenopus laevis (Xenopus Express) were
cared for by standards approved by the Institutional Animal Care and
Use Committee of the University at Buffalo State University of New York. Frogs were anesthetized by immersion in tricaine solution (1 g/l;
Sigma). Oocytes were digested by placing them in a
collagenase-containing, Ca2+-free OR2 solution (in mM: 82.5 NaCl, 2 KCl, 1 MgCl2, and 5 HEPES; pH 7.4, 1 mg/ml
collagenase, type I; Sigma). The oocytes were gently shaken for
1.5-2 h, with the enzyme solution refreshed at 1 h.
Defolliculated oocytes (stages V-VI) were injected with up
to 50 ng mRNA for a Kv1.4 channel clone originally isolated from ferret
heart (9) by using the Nanoject microinjection system
(Drummond Scientific; Broomall, PA). Oocytes were voltage clamped by
using a two-microelectrode oocyte clamp amplifier (CA-1B, Dagan;
Minneapolis, MN), and currents were recorded at room temperature. Microelectrodes with resistances of 0.5- 1.5 M
were fabricated from
1.5-mm outer diamter borosilicate glass tubing (TW150-4, WPI) with
the use of a two-stage puller and filled with 3 M KCl. The control
extracellular solution (ND-96) contained (in mM) 96 NaCl, 2 KCl, 1 MgCl2, 1.8 CaCl2, and 10 HEPES; pH adjusted to 7.4. The 98 mM K+ solution contained (in mM) 98 KCl, 1 MgCl2, 1.8 CaCl2, and 10 HEPES; pH 7.4.
Giant torn-off patches (17) were taken from some oocytes
and used as inside-out membrane patches in which intracellular solutions were controlled by a rapid solution switching device (ALA
Scientific Instruments). Microelectrodes (0.5 M
) were coated with a
mixture containing 5% parafilm and light mineral oil. The giant patch
electrode solution contained (in mM) 98 KCl, 1 MgCl2, 2.5 CaCl2, and 10 HEPES; pH adjusted to 7.4. For giant-patch
experiments, the initial bath solution was (in mM) 98 KCl, 1.8 MgCl2, 1 EGTA, and 10 HEPES; pH adjusted to7.4. Giant patch
currents sizes measured at +50 mV were 7.6 ± 7.1 nA in normal
intracellular solution and
1.02 ± 0.78 nA in
K+-free intracellular solution for fKv1.4 (means ± SD, n = 5) and 1.49 ± 1.29 nA in normal
intracellular solution and
0.16 ± 0.14 nA in
K+-free intracellular solution for fKv1.4
N (means ± SD, n = 6)
Data were digitized and analyzed by using pCLAMP (Axon Instruments). Further analysis was performed by using Clampfit (Axon Instruments), Excel (Microsoft), and Origin (Microcal Software). Data were filtered at 2 kHz. Data are shown as means ± SE. Confidence levels were calculated using Student's paired t-test.
| |
RESULTS |
|---|
|
|
|---|
High [K+]o reduces the C-type inactivation rate (31), an observation that led to the "Foot-in-the-Door" Hypothesis (2), and subsequently the Permeation Hypothesis of coupling between N- and C-type inactivation (4). A prediction of the Permeation Hypothesis is that in the presence of saturating concentrations of [K+]o, C-type inactivation should be insensitive to the intracellular K+ concentration ([K+]i).
This prediction can be tested directly in torn-off giant patches
(17) from Xenopus oocytes expressing ferret
Kv1.4
N [amino acids 2-146 are deleted (9)]
channels, which lack N-type inactivation but show robust C-type
inactivation. Contrary to the prediction of the Permeation Hypothesis,
in the presence of saturating (98 mM) levels of
[K+]o removing
[K+]i and replacing it with 98 mM
N-methyl-D-glutamic acid increased the rate of
inactivation (Fig. 1). This
demonstrates that [K+]o is not the
only coupling pathway between N- and C-type inactivation. Furthermore,
this suggests that intracellular interactions have an effect on the
extracellular conformation of the channel, which is consistent with the
Allosteric but not the Permeation Hypothesis.
|
The Allosteric Hypothesis proposes that the channel can adopt different
conformations with different likelihoods of entering the C-type
inactivated state. It therefore predicts that certain mutations on the
intracellular side of the channel will alter the properties of C-type
inactivation (37). Mutations near the extracellular mouth
of the pore that affect C-type inactivation are well known; however,
there have been few reports on intracellular mutations with similar
effects on C-type inactivation. One intracellular change that does
alter C-type inactivation is a spontaneous mutation in human Kv1.1
channels, which causes episodic ataxia (1). This mutation
occurs at the extreme intracellular mouth of the pore on S6 and
involves a valine to alanine substitution. We examined this mutation at
an equivalent position in our Kv1.4 NH2-terminal deletion
mutant: fKv1.4[V561A]
N (Fig. 2).
|
Previous studies in Kv1.1 channels showed that the steady-state
properties of C-type inactivation were unaffected by this mutation but
inactivation was significantly faster (1). Under control
conditions with 2 mM [K+]o (to mimic
amphibian extracellular fluid composition), we observed no difference
in the rate of C-type inactivation between fKv1.4
N and
fKv1.4[V561A]
N (Fig. 2, B and C). The
apparent lack of a fKv1.4[V561A]
N phenotype was unexpected,
so we examined this mutant construct more closely. In Kv1.1 the most
striking phenotypic change associated with this mutation was a dramatic
increase in the rate of recovery from C-type inactivation
(1). We examined recovery using a two-pulse protocol (Fig.
3A). Despite the apparent lack
of effect on the development of inactivation, fKv1.4[V561A]
N exhibited a dramatic increase in the rate of recovery from inactivation in 2 mM [K+]o at +40 mV, a result
qualitatively similar to the effect of the analogous mutation in Kv1.1
channels (1).
|
The increase in recovery rate seen in Fig. 3A may be
due to differences in the C-type inactivation mechanism in the two
channels. Alternatively, because C-type inactivation is coupled to
activation (19, 37, 38), the difference could be produced
by a shift in the voltage dependence of recovery. Once the channel is
sufficiently activated, inactivation proceeds with little or no voltage
dependence at positive potentials. For many channels, recovery from
inactivation is voltage dependent (18). Recovery is
thought to be energetically linked to backward movement of the voltage
sensor so that the inactivation recovery rate can be altered if the
voltage dependence of inactivation is shifted. Figure 3B
shows steady-state inactivation as a function of holding potential for
both fKv1.4
N and fKv1.4[V561A]
N. The valine-to-alanine mutation
does not shift the voltage dependence of inactivation. This is in
contrast to observations in the related, but not identical,
Shaker channel, in which the analogous valine to alanine
mutation causes a shift in voltage dependence of steady-state activation and inactivation (5).
Recovery from C-type inactivation, just like development of C-type
inactivation, is strongly sensitive to [K+]o
(31, 37, 38). We examined the effect of
[K+]o on recovery of fKv1.4
N and
fKv1.4[V561A]
N. Switching from 2 to 98 mM
[K+]o greatly increased the recovery of
fKv1.4
N but had a much smaller effect on fKv1.4[V561A]
N
recovery (Fig. 4, A and
B).
|
This alteration in recovery rate [K+]o
sensitivity suggests that the intracellular V561A mutation may have
changed K+ sensitivity at the extracellular site (31,
48). This prompted a reexamination of C-type inactivation at
positive potentials in both fKv1.4
N and fKv1.4[V561A]
N.
C-type inactivation of fKv1.4
N was slowed by switching from 2 to 98 mM [K+]o, consistent with previous
observations (Fig. 4C). However, switching from 2 to 98 mM
[K+]o resulted in an increase in C-type
inactivation of fKv1.4[V561A]
N (Fig. 4D), which is
opposite to the effect observed in Kv1.4 and other K+
channels (31, 37, 38). The change in
[K+]o affinity suggests a link between the
intracellular portion of S6 and K+ binding at the opposite
side of the channel and is not predicted by the Permeation Model.
The manipulations presented in Fig. 4 are relatively extreme changes in
[K+]o and represent changes measured at only
one voltage. To assess the range of [K+]o
over which the effect occurs and whether these changes might be
significant within the physiological and pathophysiological range of
[K+]o, we repeated these experiments on the
fKv1.4
N and fKv1.4[V561A]
N channels at 0.5, 2, 10, 25, and 98 mM [K+]o. The reversal in relationship
between [K+]o and C-type inactivation is seen
over this entire range (Fig. 5), with
inactivation of fKv1.4[V561A]
N becoming faster with increasing
[K+]o. Both the fKv1.4
N and
fKv1.4[V561A]
N channels retained the voltage-insensitivity
characteristic of C-type inactivation rates at positive potentials
(37) (Fig. 5B). Although
[K+]o has completely opposite effects on the
two channels, there is a strong relationship between
[K+]o and inactivation time constant for the
two constructs. Furthermore, the [K+]o
dependence of inactivation rate "crosses over" at 2.0 mM. This suggests that C-type inactivation was directly modified by the mutation. For example, at 0.5 mM fKv1.4[V561A]
N inactivation was
slower than in fKv1.4
N. This is important because it is possible to
explain an increase in inactivation rate by mutagenesis inducing an
additional inactivation "gate," but a slowing of inactivation requires the point mutation at V561A to have slowed the intrinsic C-type inactivation.
|
Other extracellular factors affect both the N- and C-type inactivation
characteristics of fKv1.4 channels. Changes in pHo alter
the N-type inactivation in fKv1.4 channels (Fig.
6). Extracellular acidosis increases the
rate of N-type inactivation, whereas alkalosis slows the development of
N-type inactivation. This pHo dependence suggests that
there is some form of transmembrane transduction, for changes in
pHo alter the characteristics of NH2-terminal
binding at the intracellular face of the channel. A parallel shift in the rate of C-type inactivation is observed in fKv1.4
N. This pHo dependence of C-type inactivation occurs roughly in
proportion to the changes in N-type inactivation, despite occurring on
vastly different time scales.
|
An important aspect of the relationship between N- and C-type
inactivation is that they are coupled. The increase in C-type inactivation of channel with pH might reflect a new conformational transition with altered coupling. Therefore, we examined the effect of
pHo on the rate of recovery from N- and C-type
inactivation. As was the case for development of N- and C-type
inactivation, the rates of recovery from inactivation for both fKv1.4
and fKv1.4
N were nearly identical and showed parallel shifts with
changes in pHo (Fig. 6). This suggests that
pHo-modified C-type inactivation retains the characteristic
coupling between N- and C-type inactivation (for a review see Ref.
38) in which N-type inactivation promotes rapid
development of C-type inactivation and recovery from both is governed
by C-type inactivation.
The pHo dependence of C-type inactivation is
modulated by an extracellular histidine at position 508 (8). Mutation of this histidine to a glutamine removes the
pHo dependence of N-type inactivation of
fKv1.4[H508Q] [normalized to
inactivation at pH 7.4,
inactivation at pH 6.8 is 1.07 ± 0.04 and
pH 8.0 is 0.99 ± 0.02 (n = 8, P < 0.01)] and C-type inactivation of fKv1.4[H508Q]
N [normalized
to pH 7.4,
inactivation at pH 6.8 is 1.05 ± 0.07 and pH 8.0 is 1.03 ± 0.06 (n = 4, P < 0.01), where
inactivation is the
time constant of inactivation]. The C-type nature of this coupling was confirmed using a lysine to tyrosine mutant,
fKv1.4[K532Y]
N, which inhibits C-type inactivation
(8) and abolishes the pHo dependence of both
N- and C-type inactivation [normalized to pH 7.4,
inactivation at pH 6.8 is 0.94 ± 0.02 and pH 8.0 is 0.91 ± 0.03 (n = 5, P < 0.01)]. These results provide further evidence for transmembrane
coupling of a mechanism that fulfills the criteria for C-type inactivation.
Finally, we examined the combined effects of pHo and
[K+]o on C-type inactivation of
fKv1.4[V561A]
N. Changing pHo from 7.4 to 6.8 in 2 mM
[K+]o results in an increase in the rate of
inactivation of fKv1.4[V561A]
N [from 2.98 ± 0.08 to
2.51 ± 0.02 s (n = 3, P < 0.05)], which is similar to the effect pHo has on
fKv1.4 and fKv1.4
N channels (see Fig. 6). The rate
of fKv1.4[V561A]
N inactivation at pH 6.8 can be further increased
by switching [K+]o from 2 to 98 mM [from
2.51 ± 0.02 s to 1.87 ± 0.08 s (n = 4, P < 0.01)]. This demonstrates that the
intracellular S6 mutation at V561 results in an alteration in the
[K+]o sensitivity independent of the actual
kinetic rates of C-type inactivation.
| |
DISCUSSION |
|---|
|
|
|---|
Kv1.4 channels mediate a slowly recovering outward current with upregulated expression during ischemia. Therefore, understanding the molecular basis of the kinetic behavior of Kv1.4 channels in response to changes in pH and [K+] may be of considerable physiological importance. Our data demonstrate that a mutation at an intracellular site on S6 can alter qualitative properties normally associated with the extracellular pore mouth in Kv1.4 channels. Conversely, pHo modulates N-type inactivation, which is a primarily intracellular event. Both [K+]o and pHo determine the recovery from inactivation of this channel in an additive manner through their interactions with C-type inactivation.
Protonation of an extracellular histidine (H508) affected N-type
inactivation, an intracellular process. It is unlikely that mobility of
the NH2-terminal is altered by manipulating the charge of
an extracellular amino acid. Therefore, protons binding to H508 must
alter either the availability of the NH2-terminal binding site or the rate of inactivation following NH2-terminal
binding. Either way, our data establish a link between the
extracellular H508 and conformational changes on intracellular domains
associated with inactivation. This is consistent with the relationship
between activation and inactivation in voltage-gated channels
(19, 38). Cocrystallization of KcsA and a bound
NH2-terminal domain (50) suggest that the
structure of the bound NH2-terminal domain is significantly
different from the NH2-terminal peptide in solution (47), which indicates that binding involves reciprocal
rearrangements of the
-subunit and the NH2-terminal domain.
The effect of [H+]o on N-type inactivation can be disrupted by mutating the lysine at position 532. Given that the intracellular locus of action of N-type inactivation binding with S6 is well established, it is likely that protonation of H508 communicates with both N- and C-type inactivation through S6.
The molecular basis underlying C-type inactivation is unclear, so it is defined by a mixture of functional attributes. The slow inactivation of Kv1.4 channels fits most of the classical definitions of C-type inactivation. However, a simple point mutation on the intracellular side of S6 changes the phenotype with respect to [K+]o sensitivity. This finding might cause us to conclude that the channel no longer inactivates via a C-type mechanism.
The question of whether fKv1.4[V561A]
N exhibits modified C-type
inactivation or has introduced or enhanced a second inactivation process is an interesting one. If we consider that fKv1.4[V561A]
N introduces a second independent inactivation process, then there will
be two inactivation gates with opposite [K+]o
dependence. In 2 mM [K+]o,
fKv1.4[V561A]
N inactivates at the same rate as fKv1.4
N. At
higher [K+]o, fKv1.4[V561A]
N
inactivation becomes faster, indicating that the second V561A gate is
dominant. However, when [K+]o is below 2 mM
[K+]o, the two-gate hypothesis suggests that
the inactivation rate would again become faster because the C-type
mechanism would be dominant. However, fKv1.4[V561A]
N inactivation
becomes slower when [K+]o is <2 mM,
suggesting that the S6 mutation has modified C-type inactivation rather
than introduced a new inactivation mechanism.
This complete reversal of [K+]o dependence is clearly not the result of a simple change in the K+ affinity for an external binding site. No matter how drastically the affinity was altered, there would still be the same qualitative result: an increase in [K+]o would result in a slowing of inactivation. The V561A mutation completely reversed the direction of this relationship, with an increase in [K+]o increasing inactivation. This cannot be explained in terms of the Permeation Model. The anomalous [K+]o dependence of C-type inactivation is strong evidence for allosteric interactions between the intracellular and extracellular faces of the channel.
The intracellular V561 mutation leading to an alteration of phenotype in response to [K+]o manipulations is similar to response of mutated Shaker channels to heavy metal binding. A threonine-to-cysteine mutation (T449C) in the extracellular mouth of the Shaker channel reverses the relationship between extracellular zinc and the rate of C-type inactivation (48).
The pH dependence of inactivation of fKv1.4[V561A]
N provides
further evidence that the properties of C-type inactivation have been
modified. The ability of the K532Y mutation to disrupt pH dependence of
Kv1.4 suggests that the pH modulation of inactivation occurs through
the C-type inactivation mechanism. fKv1.4[V561A]
N shows an
increase in the rate of inactivation with acidosis similar to the
wild-type channel. Given the similarity in response to acidosis of
inactivation of the wild-type and V561A channels, it seems simplest to
conclude that fKv1.4[V561A]
N alters the properties of C-type
inactivation rather than inducing a second inactivation mechanism.
The data in this paper demonstrate transmembrane energetic interactions on gating, which require some degree of change in protein conformation in response to the manipulations. This is particularly apparent in the ability of pHo to modulate both N- and C-type inactivation. It clearly establishes a physiologically relevant role for allosteric interactions associated with C-type inactivation, particularly in determining the role of pH and [K+]o sensitivity, as well as recovery characteristics for coupled N- and C-type inactivation.
The relationship between N-type inactivation and C-type inactivation
may have broader implications for members of the Kv1 family. The role
of the NH2-terminal domain of the
-subunit in mediating
N-type inactivation in the fKv1.4
N channel (37) is virtually identical to that established by the landmark studies of
Hoshi et al. (21) in Shaker K+
channels. The NH2-terminal domain from the Kv
1.2 subunit
also accelerates C-type inactivation in fKv1.4
N (33).
The NH2 terminus of the Kv
1.2 subunit has a lower
affinity for the binding site and more rapid binding kinetics to the
inner vestibule so the NH2-terminal domain from Kv1.2
subunit functions more like a rapid open channel blocker such as
quinidine (see later in text) (33, 39). This has been
studied in Kv1.5 channels by Uebele et al. (41) for the
Kv
1.3 subunit and Kv1.5 combination. Kv
1.3 also confers a
voltage-dependent, partial inactivation (
= 5.76 ± 0.14 ms at +50 mV) and an enhanced slow (possibly C-type) inactivation. In
this channel combination, mutation of V512A (which is homologous to
V561A in Kv1.4) did not affect the rapid component of Kv
1.3-mediated inactivation, whereas a mutation at the external mouth of the pore
(R485Y, equivalent to our K532Y mutation) increased the extent of fast
inactivation while preventing the enhancement of slow inactivation.
These studies suggest that NH2-terminal binding is
allosterically linked to the external pore for a variety of Kv1 channel
complexes and may be a critical determinant of many key properties of
channel gating.
The demonstration of physical coupling between intracellular and extracellular domains associated with C-type inactivation supports the idea that the Allosteric Hypothesis is physiologically significant. Unquestionably, permeant ion concentrations also play an important role (31). Our experiment with [K+]i substitution used high [K+]o to saturate an external site. This helps eliminate the role of this external site in mediating the increase in the inactivation rate observed in these experiments. However, several previous studies examining the effects of changes in permeant ionic species on different sides of the membrane suggested that there may be additional permeant ion binding sites within the channel (12, 13, 16, 45, 46). Removal of [K+]i may be mediating its effects through changes in the occupancy of such sites. The nature and exact location of such sites remain unknown.
Permeant ions can exert a strong effect on gating transitions such as activation, open probability, channel dwell time, and inactivation (19). In the KcsA channel, intracellular ion binding can change the conformation of the channel at physically distant locations (30, 35). The KcsA channel pore is quite narrow, even in domains outside the selectivity filter (11). Water in such narrow pores is likely to have considerable structure, and the presence of hydrated ions in this small space may affect local protein-water interactions (23). Thus, even if a specific binding site does not exist, this is a potential mechanism by which the concentration or species of flowing ions can alter the stability of different channel conformations.
Figure 7 represents a
projection of the fKv1.4 sequence onto the KcsA crystal structure
(11) and shows the regions that have been altered or
explored in this paper (V561, K532, and H508). Clearly, these sites are
physically remote from one another and from the permeation pathway. The
insensitivity of the K532 and H508 mutant channels to pHo
indicates there must be some interaction between these two sites, but
because of the high energy of solvation, it is unlikely that this
interaction is electrostatic. It is also unlikely that there is an
electrostatic interaction between the charge on H508 at the
extracellular side of the membrane and the activity of the positively
charged NH2-terminal domain binding to the intracellular
side of the channel: given the high dielectric constant of water, it is
not energetically feasible. Furthermore, acidosis speeds N-type
inactivation, whereas positive charge on H508 would repel the
NH2 terminal, thereby slowing inactivation. In addition,
electrostatic interactions do not seem likely with a distant and
uncharged valine or alanine at position 561. The mutation of a valine
to an alanine does not add any additional charge that would contribute
an electrostatic component to binding of K+ at
extracellular sites. The most likely mechanism is that transmembrane effects are transduced through S6 and possibly other domains, in a
process somewhat analogous to activation of the KcsA channel by
intracellular protons (10).
|
In summary, our results demonstrate a strong coupling of intracellular domains and extracellular domains associated with S6 and the flanking regions surrounding the extracellular mouth of the pore. The most striking change seen in the V561A mutation was that the [K+]o sensitivity of C-type inactivation was reversed, with inactivation becoming faster with increasing [K+]o. This qualitative behavior is similar to that observed for the Kv4 family of channels (25) and suggests that the mechanism(s) of inactivation between these two channels may be closely related, despite the disparities in biophysical properties. C-type inactivation-like mechanisms are also present in more distantly related channels, such as human ether-à-go-go-related gene (42, 43). In all cases, involvement of mutations on S6 have been noted to have a strong modulatory effect on function, despite being relatively remote from the mouth of the putative extracellular pore domain. Furthermore, it seems that C-type inactivation may have both an extracellular and intracellular "gate" similar to that proposed for activation of the KcsA channel. Understanding the coupling between these regions will enhance our understanding of the time and use dependence of many antiarrhythmic drugs.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Dr. Harold Strauss for useful advice and suggestions.
| |
FOOTNOTES |
|---|
This study was supported in part by National Heart, Lung, and Blood Institute Grant R01 HL-59526-01, National Science Foundation Knowledge and Distributed Intelligence Grant DBI-9873173, and an Established Investigator Award from the American Heart Association.
Address for reprint requests and other correspondence: R. L. Rasmusson, Dept. of Physiology and Biophysics, 124 Sherman Hall, State Univ. of NY at Buffalo, Buffalo, NY 14214.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
First published August 29, 2002;10.1152/ajpheart.00392.2002
Received 6 May 2002; accepted in final form 23 August 2002.
| |
REFERENCES |
|---|
|
|
|---|
1.
Adelman, JP,
Bond CT,
Pessia M,
and
Maylie J.
Episodic ataxia results from voltage-dependent potassium channels with altered functions.
Neuron
15:
1449-1454,
1995.
2.
Armstrong, CM.
Interaction of tetraethylammonium ion derivatives with the potassium channels of giant axons.
J Gen Physiol
58:
413-437,
1971.
3.
Barry, DM,
and
Nerbonne JM.
Myocardial potassium channels: electrophysiological and molecular diversity (Review).
Annu Rev Physiol
58:
363-394,
1996.
4.
Baukrowitz, T,
and
Yellen G.
Modulation of K+ current by frequency and external [K+]: a tale of two inactivation mechanisms.
Neuron
15:
951-960,
1995.
5.
Boland, LM,
Price DL,
and
Jackson KA.
Episodic ataxia/myokymia mutations functionally expressed in the Shaker potassium channel.
Neuroscience
91:
1557-1564,
1999.
6.
Busch, AE,
Hurst RS,
North RA,
Adelman JP,
and
Kavanaugh MP.
Current inactivation involves a histidine residue in the pore of the rat lymphocyte potassium channel RGK5.
Biochem Biophys Res Commun
179:
1384-1390,
1991.
7.
Choi, KL,
Aldrich RW,
and
Yellen G.
Tetraethylammonium blockade distinguishes two inactivation mechanisms in voltage-activated K+ channels.
Proc Natl Acad Sci USA
88:
5092-5095,
1991.
8.
Claydon, TW,
Boyett MR,
Sivaprasadarao A,
Ishii K,
Owen JM,
O'Beirne HA,
Leach R,
Komukai K,
and
Orchard CH.
Inhibition of the K+ channel kv1.4 by acidosis: protonation of an extracellular histidine slows the recovery from N-type inactivation.
J Physiol
526:
253-264,
2000.
9.
Comer, MB,
Campbell DL,
Rasmusson RL,
Lamson DR,
Morales MJ,
Zhang Y,
and
Strauss HC.
Cloning and characterization of an Ito-like potassium channel from ferret ventricle.
Am J Physiol Heart Circ Physiol
267:
H1383-H1395,
1994.
10.
Cuello, LG,
Romero JG,
Cortes DM,
and
Perozo E.
pH-dependent gating in the Streptomyces lividans K+ channel.
Biochemistry
37:
3229-3236,
1998.
11.
Doyle, DA,
Morais CJ,
Pfuetzner RA,
Kuo A,
Gulbis JM,
Cohen SL,
Chait BT,
and
MacKinnon R.
The structure of the potassium channel: molecular basis of K+ conduction and selectivity (see Comments).
Science
280:
69-77,
1998.
12.
Fan, JS,
Jiang M,
Dun W,
McDonald TV,
and
Tseng GN.
Effects of outer mouth mutations on hERG channel function: a comparison with similar mutations in the Shaker channel.
Biophys J
76:
3128-3140,
1999.
13.
Fedida, D,
Maruoka ND,
and
Lin S.
Modulation of slow inactivation in human cardiac Kv1.5 channels by extra- and intracellular permeant cations.
J Physiol
515:
315-329,
1999.
14.
Ficker, E,
Jarolimek W,
Kiehn J,
Baumann A,
and
Brown AM.
Molecular determinants of dofetilide block of HERG K+ channels.
Circ Res
82:
386-395,
1998.
15.
Gidh-Jain, M,
Huang B,
Jain P,
and
El Sherif N.
Differential expression of voltage-gated K+ channel genes in left ventricular remodeled myocardium after experimental myocardial infarction.
Circ Res
79:
669-675,
1996.
16.
Grigoriev, NG,
Spafford JD,
and
Spencer AN.
Residues in a jellyfish Shaker-like channel involved in modulation by external potassium.
J Neurophysiol
82:
1740-1747,
1999.
17.
Hilgemann, DW.
Regulation and deregulation of cardiac Na+-Ca2+ exchange in giant excised sarcolemmal membrane patches.
Nature
344:
242-245,
1990.
19.
Hille, B.
Ion Channels of Excitable Membranes. Sunderland, MA: Sinauer, 2001.
20.
Holmgren, M,
Jurman ME,
and
Yellen G.
N-type inactivation and the S4-S5 region of the Shaker K+ channel.
J Gen Physiol
108:
195-206,
1996.
21.
Hoshi, T,
Zagotta WN,
and
Aldrich RW.
Biophysical and molecular mechanisms of Shaker potassium channel inactivation (see Comments).
Science
250:
533-538,
1990.
22.
Hoshi, T,
Zagotta WN,
and
Aldrich RW.
Two types of inactivation in Shaker K+ channels: effects of alterations in the carboxy-terminal region.
Neuron
7:
547-556,
1991.
23.
Hummer, G,
Rasaiah JC,
and
Noworyta JP.
Water conduction through the hydrophobic channel of a carbon nanotube (see Comments).
Nature
414:
188-190,
2001.
24.
Isacoff, EY,
Jan YN,
and
Jan LY.
Putative receptor for the cytoplasmic inactivation gate in the Shaker K+ channel.
Nature
353:
86-90,
1991.
25.
Jerng, HH,
and
Covarrubias M.
K+ channel inactivation mediated by the concerted action of the cytoplasmic N- and C-terminal domains.
Biophys J
72:
163-174,
1997.
26.
Kaprielian, R,
Wickenden AD,
Kassiri Z,
Parker TG,
Liu PP,
and
Backx PH.
Relationship between K+ channel down-regulation and [Ca2+]i in rat ventricular myocytes following myocardial infarction.
J Physiol
517:
229-245,
1999.
27.
Lee, JK,
Nishiyama A,
Kambe F,
Seo H,
Takeuchi S,
Kamiya K,
Kodama I,
and
Toyama J.
Downregulation of voltage-gated K+ channels in rat heart with right ventricular hypertrophy.
Am J Physiol Heart Circ Physiol
277:
H1725-H1731,
1999.
28.
Lipkind, GM,
Hanck DA,
and
Fozzard HA.
A structural motif for the voltage-gated potassium channel pore.
Proc Natl Acad Sci USA
92:
9215-9219,
1995.
29.
Liu, Y,
Jurman ME,
and
Yellen G.
Dynamic rearrangement of the outer mouth of a K+ channel during gating.
Neuron
16:
859-867,
1996.
30.
Liu, YS,
Sompornpisut P,
and
Perozo E.
Structure of the KcsA channel intracellular gate in the open state.
Nat Struct Biol
8:
883-887,
2001.
31.
Lopez-Barneo, J,
Hoshi T,
Heinemann SH,
and
Aldrich RW.
Effects of external cations and mutations in the pore region on C-type inactivation of Shaker potassium channels.
Receptors Channels
1:
61-71,
1993.
32.
Lopez, GA,
Jan YN,
and
Jan LY.
Evidence that the S6 segment of the Shaker voltage-gated K+ channel comprises part of the pore.
Nature
367:
179-182,
1994.
33.
Morales, MJ,
Wee JO,
Wang S,
Strauss HC,
and
Rasmusson RL.
The N-terminal domain of a K+ channel
-subunit increases the rate of C-type inactivation from the cytoplasmic side of the channel.
Proc Natl Acad Sci USA
93:
15119-15123,
1996.
34.
Nishiyama, A,
Ishii DN,
Backx PH,
Pulford BE,
Birks BR,
and
Tamkun MM.
Altered K+ channel gene expression in diabetic rat ventricle: isoform switching between Kv4.2 and Kv14.
Am J Physiol Heart Circ Physiol
281:
H1800-H1807,
2001.
35.
Perozo, E,
Cortes DM,
and
Cuello LG.
Structural rearrangements underlying K+-channel activation gating (see Comments).
Science
285:
73-78,
1999.
36.
Pongs, O.
Molecular biology of voltage-dependent potassium channels (Review).
Physiol Rev
72:
S69-S88,
1992.
37.
Rasmusson, RL,
Morales MJ,
Castellino RC,
Zhang Y,
Campbell DL,
and
Strauss HC.
C-type inactivation controls recovery in a fast inactivating cardiac K+ channel (Kv1.4) expressed in Xenopus oocytes.
J Physiol
489:
709-721,
1995.
38.
Rasmusson, RL,
Morales MJ,
Wang S,
Liu S,
Campbell DL,
Brahmajothi MV,
and
Strauss HC.
Inactivation of voltage-gated cardiac K+ channels (Review).
Circ Res
82:
739-750,
1998.
39.
Rasmusson, RL,
Wang S,
Castellino RC,
Morales MJ,
and
Strauss HC.
The beta subunit, Kv
-1.2, acts as a rapid open channel blocker of NH2-terminal deleted Kv14
-subunits.
Adv Exp Med Biol
430:
29-37,
1997.
40.
Snyders, DJ,
and
Chaudhary A.
High affinity open channel block by dofetilide of HERG expressed in a human cell line.
Mol Pharmacol
49:
949-955,
1996.
41.
Uebele, VN,
England SK,
Gallagher DJ,
Snyders DJ,
Bennett PB,
and
Tamkun MM.
Distinct domains of the voltage-gated K+ channel Kv
1.3
-subunit affect voltage-dependent gating.
Am J Physiol Cell Physiol
274:
C1485-C1495,
1998.
42.
Wang, S,
Morales MJ,
Liu S,
Strauss HC,
and
Rasmusson RL.
Time, voltage and ionic concentration dependence of rectification of herg expressed in Xenopus oocytes.
FEBS Lett
389:
167-173,
1996.
43.
Wang, S,
Morales MJ,
Liu S,
Strauss HC,
and
Rasmusson RL.
Modulation of HERG affinity for E-4031 by [K+]o and C-type inactivation.
FEBS Lett
417:
43-47,
1997.
44.
Wang S, Morales MJ, Qu Y, Bett GCL, Strauss HC, and Rasmusson RL.
Kv1.4 channel block by quinidine: evidence for a drug-induced
allosteric effect. J Physiol. In press.
45.
Wang, Z,
Zhang X,
and
Fedida D.
Gating current studies reveal both intra- and extracellular cation modulation of K+ channel deactivation.
J Physiol
515:
331-339,
1999.
46.
Wang, Z,
Zhang X,
and
Fedida D.
Regulation of transient Na+ conductance by intra- and extracellular K+ in the human delayed rectifier K+ channel Kv1.5.
J Physiol
523:
575-591,
2000.
47.
Wissmann, R,
Baukrowitz T,
Kalbacher H,
Kalbitzer HR,
Ruppersberg JP,
Pongs O,
Antz C,
and
Fakler B.
NMR structure and functional characteristics of the hydrophilic N terminus of the potassium channel beta-subunit Kvbeta1.1.
J Biol Chem
274:
35521-35525,
1999.
48.
Yellen, G,
Sodickson D,
Chen TY,
and
Jurman ME.
An engineered cysteine in the external mouth of a K+ channel allows inactivation to be modulated by metal binding.
Biophys J
66:
1068-1075,
1994.
49.
Zagotta, WN,
Hoshi T,
and
Aldrich RW.
Restoration of inactivation in mutants of Shaker potassium channels by a peptide derived from ShB (see Comments).
Science
250:
568-571,
1990.
50.
Zhou, M,
Morais-Cabral JH,
Mann S,
and
MacKinnon R.
Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors (see Comments).
Nature
411:
657-661,
2001.
This article has been cited by other articles:
![]() |
G. Panaghie, K. Purtell, K.-K. Tai, and G. W. Abbott Voltage-Dependent C-Type Inactivation in a Constitutively Open K+ Channel Biophys. J., September 15, 2008; 95(6): 2759 - 2778. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. C. L. Bett and R. L. Rasmusson Modification of K+ channel-drug interactions by ancillary subunits J. Physiol., February 15, 2008; 586(4): 929 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Imbrici, M. C. D'Adamo, A. Cusimano, and M. Pessia Episodic ataxia type 1 mutation F184C alters Zn2+-induced modulation of the human K+ channel Kv1.4-Kv1.1/Kvbeta1.1 Am J Physiol Cell Physiol, February 1, 2007; 292(2): C778 - C787. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Putnam, J. A. Filosa, and N. A. Ritucci Cellular mechanisms involved in CO2 and acid signaling in chemosensitive neurons Am J Physiol Cell Physiol, December 1, 2004; 287(6): C1493 - C1526. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Somodi, Z. Varga, P. Hajdu, J. G. Starkus, D. I. Levy, R. Gaspar, and G. Panyi pH-dependent modulation of Kv1.3 inactivation: role of His399 Am J Physiol Cell Physiol, October 1, 2004; 287(4): C1067 - C1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sackin, L.G. Palmer, and M. Krambis Potassium-Dependent Slow Inactivation of Kir1.1 (ROMK) Channels Biophys. J., April 1, 2004; 86(4): 2145 - 2155. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||